Charles Schwab’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-273,002
Closed -$1.15M 3756
2023
Q1
$1.15M Buy
273,002
+2,901
+1% +$12.2K ﹤0.01% 2691
2022
Q4
$1.62M Buy
270,101
+12,405
+5% +$74.6K ﹤0.01% 2626
2022
Q3
$1.5M Buy
257,696
+16,684
+7% +$97.1K ﹤0.01% 2664
2022
Q2
$1.44M Buy
241,012
+203,516
+543% +$1.22M ﹤0.01% 2662
2022
Q1
$176K Hold
37,496
﹤0.01% 3327
2021
Q4
$93K Hold
37,496
﹤0.01% 3443
2021
Q3
$111K Buy
37,496
+17,496
+87% +$51.8K ﹤0.01% 3370
2021
Q2
$50K Hold
20,000
﹤0.01% 3371
2021
Q1
$59K Hold
20,000
﹤0.01% 3424
2020
Q4
$65K Buy
+20,000
New +$65K ﹤0.01% 3340
2019
Q2
Sell
-95,500
Closed -$93K 3333
2019
Q1
$93K Hold
95,500
﹤0.01% 3095
2018
Q4
$71K Hold
95,500
﹤0.01% 3113
2018
Q3
$207K Sell
95,500
-14,337
-13% -$31.1K ﹤0.01% 3073
2018
Q2
$547K Buy
+109,837
New +$547K ﹤0.01% 2777
2016
Q2
Sell
-39,370
Closed -$210K 3224
2016
Q1
$210K Buy
39,370
+9,620
+32% +$51.3K ﹤0.01% 2886
2015
Q4
$366K Buy
29,750
+10,670
+56% +$131K ﹤0.01% 2784
2015
Q3
$279K Hold
19,080
﹤0.01% 2860
2015
Q2
$373K Hold
19,080
﹤0.01% 2789
2015
Q1
$346K Hold
19,080
﹤0.01% 2779
2014
Q4
$451K Hold
19,080
﹤0.01% 2657
2014
Q3
$462K Hold
19,080
﹤0.01% 2619
2014
Q2
$537K Hold
19,080
﹤0.01% 2598
2014
Q1
$649K Buy
19,080
+3,020
+19% +$103K ﹤0.01% 2488
2013
Q4
$309K Hold
16,060
﹤0.01% 2794
2013
Q3
$267K Hold
16,060
﹤0.01% 2804
2013
Q2
$160K Buy
+16,060
New +$160K ﹤0.01% 2978